+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
Human Growth Hormone Market 2024-2028 - Product Thumbnail Image

Human Growth Hormone Market 2024-2028

  • Report
  • August 2024
  • 151 Pages
  • Global
From
Insulin Market 2024-2028 - Product Thumbnail Image

Insulin Market 2024-2028

  • Report
  • August 2024
  • 161 Pages
  • Global
From
From
From
From
Endocrinology Drugs Market 2024-2028 - Product Thumbnail Image

Endocrinology Drugs Market 2024-2028

  • Report
  • May 2024
  • 177 Pages
  • Global
From
From
From
From
From
From
Global Markets for Insulin Drug and Delivery Technologies - Product Thumbnail Image

Global Markets for Insulin Drug and Delivery Technologies

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Hepatitis Therapeutics Global Market Report 2024 - Product Thumbnail Image

Hepatitis Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator